Company: OPGN
Filing Date: 2025-08-21
Form Type: 10-K
Source: 0001829126-25-006628
Chunk: 2445

Company: OPGEN INC
Filing Date: 2025-08-21
Form: 10-K
Item: Item 8
Chunk 2445
---

    Stock compensation expense

    602,433

    235,974

    Loss on sale of equipment

    -

    10,288

    Cash bonus taken in the form of stock compensation

    -

    283,554

    Loss on deconsolidation of subsidiaries

    75,138

    12,979,061

    Change in fair value of derivative financial instruments

    -

    (64,259
    )
  
    Change in fair value of EIB loan guaranty

    (10,873,867
    )

    -

    Gain on impairment adjustment

    (2,079,575
    )

    -

    Gain on settlement of compensation expense

    (570,785
    )

    -

    Impairment of right-of-use asset

    -

    849,243

    Impairment of property and equipment

    -

    1,231,874

    Changes in operating assets and liabilities:

    Accounts receivable

    74,058

    39,115

    Inventory

    54,830

    748,445

    Other assets

    (4,657,565
    )

    (259,173
    )
  
    Accounts payable

    134,047

    (24,158
    )
  
    Accrued compensation and other liabilities

    284,745

    (1,612,944
    )
  
    Deferred revenue

    (25,926
    )

    74,109

    Net cash used in operating activities

    (4,869,744
    )

    (14,319,542
    )
  
    Cash flows from investing activities:

    Purchases of property and equipment

    -

    (800,412
    )
  
    Net cash used in investing activities

    -

    (800,412
    )
  
    Cash flows from financing activities:

    Proceeds from issuance of common stock and warrants, net of issuance costs

    -

    12,041,168

    Proceeds from issuance of common stock, net of issuance costs

    1,988,359

    -

    Proceeds from issuance of preferred stock, net of issuance costs

    2,950,217

    250,000

    Proceeds from short-term insurance financing

    300,926

    -

    Payments on short-term insurance financing

    (210,648